On November 20, 2023, Mereo Biopharma Group Plc ADR (NASDAQ: MREO) opened at $2.10, higher 5.29% from the last session. During the day, the shares moved up to $2.23 and dropped to $2.03 before settling in for the closing price of $2.08. Price fluctuations for MREO have ranged from $0.49 to $2.39 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -20.00%. Company’s average yearly earnings per share was noted 28.34% at the time writing. With a float of $128.36 million, this company’s outstanding shares have now reached $128.39 million.
The extent of productivity of a business whose workforce counts for 36 workers is very important to gauge.
Mereo Biopharma Group Plc ADR (MREO) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mereo Biopharma Group Plc ADR is 0.02%, while institutional ownership is 57.25%.
Mereo Biopharma Group Plc ADR (MREO) Performance Highlights and Predictions
This company achieved a return on equity of -43.51. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.34% per share during the next fiscal year.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Trading Performance Indicators
Check out the current performance indicators for Mereo Biopharma Group Plc ADR (MREO). In the past quarter, the stock posted a quick ratio of 3.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 31.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.25 and is forecasted to reach -0.03 in one year’s time.
Technical Analysis of Mereo Biopharma Group Plc ADR (MREO)
The latest stats from [Mereo Biopharma Group Plc ADR, MREO] show that its last 5-days average volume of 0.99 million was inferior to 1.33 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 50.67%. Additionally, its Average True Range was 0.17.
During the past 100 days, Mereo Biopharma Group Plc ADR’s (MREO) raw stochastic average was set at 84.85%, which indicates a significant increase from 60.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.26% in the past 14 days, which was lower than the 77.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.67, while its 200-day Moving Average is $1.27. Now, the first resistance to watch is $2.27. This is followed by the second major resistance level at $2.35. The third major resistance level sits at $2.47. If the price goes on to break the first support level at $2.07, it is likely to go to the next support level at $1.95. Assuming the price breaks the second support level, the third support level stands at $1.87.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Key Stats
There are currently 124,986K shares outstanding in the company with a market cap of 281.17 million. Presently, the company’s annual sales total 0 K according to its annual income of -42,300 K.